Osteoporosis: A Review of Novel Agents

This article summarizes two specific agents that were approved by the Food and Drug Administration within the last few years: abaloparatide (Tymlos) and romosozumab (Evenity). This article also highlights the crucial role that nursing staff may play in the management of osteoporosis.
Source: Orthopaedic Nursing - Category: Nursing Tags: Pharmacology Source Type: research